• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原癌基因产物p120CBL以及衔接蛋白CRKL和c-CRK将c-ABL、p190BCR/ABL和p210BCR/ABL与磷脂酰肌醇-3'激酶途径相连。

The proto-oncogene product p120CBL and the adaptor proteins CRKL and c-CRK link c-ABL, p190BCR/ABL and p210BCR/ABL to the phosphatidylinositol-3' kinase pathway.

作者信息

Sattler M, Salgia R, Okuda K, Uemura N, Durstin M A, Pisick E, Xu G, Li J L, Prasad K V, Griffin J D

机构信息

Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA.

出版信息

Oncogene. 1996 Feb 15;12(4):839-46.

PMID:8632906
Abstract

Chronic myelogenous leukemia (CML) and some acute lymphoblastic leukemias (ALL) are caused by the t(9;22) chromosome translocation, which produces the constitutively activated BCR/ABL tyrosine kinase. When introduced into factor dependent hematopoietic cell lines, BCR/ABL induces the tyrosine phosphorylation of many cellular proteins. One prominent BCR/ABL substrate is p120CBL, the cellular homolog of the v-Cbl oncoprotein. In an effort to understand the possible contribution of p120CBL to transformation by BCR/ABL, we looked for cellular proteins which associate with p120CBL in hematopoietic cell lines transformed by BCR/ABL. In addition to p210BCR/ABL and c-ABL, p120CBL coprecipitated with an 85 kDa phosphoprotein, which was identified as the p85 subunit of PI3K. Anti-p120CBL immunoprecipitates from BCR/ABL-transformed, but not from untransformed, cell lines contained PI3K lipid kinase activity. Interestingly, the adaptor proteins CRKL and c-CRK were also found in these complexes. In vitro binding studies indicated that the SH2 domains of CRKL and c-CRK bound directly to p120CBL, while the SH3 domains of c-CRK and CRKL bound to BCR/ABL and c-ABL. The N-terminal and the C-terminal SH2 and the SH3 domain of p85PI3K bound directly in vitro to p120CBL. The ABL-SH2, but not ABL-SH3, could also bind to p120CBL. These data suggest that BCR/ABL may induce the formation of multimeric complexes of signaling proteins which include p120CBL, PI3K, c-CRK or CRKL, c-ABL and BCR/ABL itself.

摘要

慢性粒细胞白血病(CML)和一些急性淋巴细胞白血病(ALL)是由t(9;22)染色体易位引起的,该易位产生组成型激活的BCR/ABL酪氨酸激酶。当将其导入依赖因子的造血细胞系时,BCR/ABL会诱导许多细胞蛋白的酪氨酸磷酸化。一个突出的BCR/ABL底物是p120CBL,它是v-Cbl癌蛋白的细胞同源物。为了了解p120CBL对BCR/ABL转化的可能作用,我们在BCR/ABL转化的造血细胞系中寻找与p120CBL相关的细胞蛋白。除了p210BCR/ABL和c-ABL外,p120CBL还与一种85 kDa的磷蛋白共沉淀,该磷蛋白被鉴定为PI3K的p85亚基。来自BCR/ABL转化细胞系而非未转化细胞系的抗p120CBL免疫沉淀物含有PI3K脂质激酶活性。有趣的是,接头蛋白CRKL和c-CRK也存在于这些复合物中。体外结合研究表明,CRKL和c-CRK的SH2结构域直接与p120CBL结合,而c-CRK和CRKL的SH3结构域与BCR/ABL和c-ABL结合。p85PI3K的N端和C端SH2以及SH3结构域在体外直接与p120CBL结合。ABL-SH2而非ABL-SH3也能与p120CBL结合。这些数据表明,BCR/ABL可能诱导信号蛋白多聚体复合物的形成,这些复合物包括p120CBL、PI3K、c-CRK或CRKL、c-ABL以及BCR/ABL自身。

相似文献

1
The proto-oncogene product p120CBL and the adaptor proteins CRKL and c-CRK link c-ABL, p190BCR/ABL and p210BCR/ABL to the phosphatidylinositol-3' kinase pathway.原癌基因产物p120CBL以及衔接蛋白CRKL和c-CRK将c-ABL、p190BCR/ABL和p210BCR/ABL与磷脂酰肌醇-3'激酶途径相连。
Oncogene. 1996 Feb 15;12(4):839-46.
2
The BCR/ABL oncogene alters interaction of the adapter proteins CRKL and CRK with cellular proteins.BCR/ABL致癌基因改变衔接蛋白CRKL和CRK与细胞蛋白的相互作用。
Leukemia. 1997 Mar;11(3):376-85. doi: 10.1038/sj.leu.2400590.
3
Tyrosine phosphorylation of p120cbl in BCR/abl transformed hematopoietic cells mediates enhanced association with phosphatidylinositol 3-kinase.在BCR/abl转化的造血细胞中,p120cbl的酪氨酸磷酸化介导了与磷脂酰肌醇3激酶增强的结合。
Oncogene. 1997 May 8;14(18):2217-28. doi: 10.1038/sj.onc.1201049.
4
p210BCR/ABL induces formation of complexes containing focal adhesion proteins and the protooncogene product p120c-Cbl.p210BCR/ABL诱导包含粘着斑蛋白和原癌基因产物p120c-Cbl的复合物形成。
Exp Hematol. 1996 Feb;24(2):310-3.
5
p130CAS forms a signaling complex with the adapter protein CRKL in hematopoietic cells transformed by the BCR/ABL oncogene.在由BCR/ABL致癌基因转化的造血细胞中,p130CAS与衔接蛋白CRKL形成信号复合物。
J Biol Chem. 1996 Oct 11;271(41):25198-203. doi: 10.1074/jbc.271.41.25198.
6
CRKL links p210BCR/ABL with paxillin in chronic myelogenous leukemia cells.在慢性粒细胞白血病细胞中,CRKL将p210BCR/ABL与桩蛋白连接起来。
J Biol Chem. 1995 Dec 8;270(49):29145-50. doi: 10.1074/jbc.270.49.29145.
7
Steel factor induces tyrosine phosphorylation of CRKL and binding of CRKL to a complex containing c-kit, phosphatidylinositol 3-kinase, and p120(CBL).Steel因子诱导CRKL的酪氨酸磷酸化以及CRKL与包含c-kit、磷脂酰肌醇3激酶和p120(CBL)的复合物的结合。
J Biol Chem. 1997 Apr 11;272(15):10248-53. doi: 10.1074/jbc.272.15.10248.
8
Interactions of CBL with BCR-ABL and CRKL in BCR-ABL-transformed myeloid cells.在BCR-ABL转化的髓系细胞中CBL与BCR-ABL和CRKL的相互作用。
J Biol Chem. 1997 Jun 27;272(26):16170-5. doi: 10.1074/jbc.272.26.16170.
9
BCR/ABL-induced leukemogenesis causes phosphorylation of Hef1 and its association with Crkl.BCR/ABL诱导的白血病发生导致Hef1磷酸化及其与Crkl的结合。
J Biol Chem. 1997 Dec 19;272(51):32649-55. doi: 10.1074/jbc.272.51.32649.
10
The two major sites of cbl tyrosine phosphorylation in abl-transformed cells select the crkL SH2 domain.在abl转化细胞中,cbl酪氨酸磷酸化的两个主要位点选择了crkL SH2结构域。
Oncogene. 1996 May 2;12(9):1981-9.

引用本文的文献

1
Pathological Mechanisms Involved in HIV-Associated Lymphomagenesis: Novel Targeted Therapeutic Approaches.HIV相关淋巴瘤发生的病理机制:新型靶向治疗方法。
Cells. 2025 May 13;14(10):705. doi: 10.3390/cells14100705.
2
Autophagy and Cancer: Insights into Molecular Mechanisms and Therapeutic Approaches for Chronic Myeloid Leukemia.自噬与癌症:慢性髓性白血病分子机制及治疗方法的见解
Biomolecules. 2025 Feb 2;15(2):215. doi: 10.3390/biom15020215.
3
PI3-kinase inhibition as a strategy to suppress the leukemic stem cell niche in Ph+ chronic myeloid leukemia.
抑制PI3激酶作为抑制Ph+慢性髓性白血病中白血病干细胞微环境的一种策略。
Am J Cancer Res. 2021 Dec 15;11(12):6042-6059. eCollection 2021.
4
Bifunctional Role of CrkL during Bone Remodeling.CrkL 在骨重塑过程中的双重功能作用。
Int J Mol Sci. 2021 Jun 29;22(13):7007. doi: 10.3390/ijms22137007.
5
B-cell clonogenic activity of HIV-1 p17 variants is driven by PAR1-mediated EGF transactivation.HIV-1 p17变体的B细胞克隆活性由PAR1介导的表皮生长因子(EGF)反式激活驱动。
Cancer Gene Ther. 2021 Jun;28(6):649-666. doi: 10.1038/s41417-020-00246-9. Epub 2020 Oct 22.
6
Comparison of effects of midostaurin, crenolanib, quizartinib, gilteritinib, sorafenib and BLU-285 on oncogenic mutants of KIT, CBL and FLT3 in haematological malignancies.比较米哚妥林、克立替尼、quizartinib、吉特替尼、索拉非尼和 BLU-285 对血液系统恶性肿瘤中 KIT、CBL 和 FLT3 致癌突变体的影响。
Br J Haematol. 2019 Nov;187(4):488-501. doi: 10.1111/bjh.16092. Epub 2019 Jul 15.
7
CRKL regulates alternative splicing of cancer-related genes in cervical cancer samples and HeLa cell.CRKL 调节宫颈癌样本和 HeLa 细胞中与癌症相关基因的可变剪接。
BMC Cancer. 2019 May 27;19(1):499. doi: 10.1186/s12885-019-5671-8.
8
Crk adaptor proteins mediate actin-dependent T cell migration and mechanosensing induced by the integrin LFA-1.Crk 衔接蛋白介导整合素 LFA-1 诱导的肌动蛋白依赖性 T 细胞迁移和机械感知。
Sci Signal. 2018 Dec 11;11(560):eaat3178. doi: 10.1126/scisignal.aat3178.
9
Inhibition of SDF-1-induced migration of oncogene-driven myeloid leukemia by the L-RNA aptamer (Spiegelmer), NOX-A12, and potentiation of tyrosine kinase inhibition.L-RNA适配体( Spiegelmer) NOX-A12对基质细胞衍生因子-1诱导的癌基因驱动的髓系白血病迁移的抑制作用以及酪氨酸激酶抑制的增强作用
Oncotarget. 2017 Nov 6;8(66):109973-109984. doi: 10.18632/oncotarget.22409. eCollection 2017 Dec 15.
10
Givinostat, a type II histone deacetylase inhibitor, induces potent caspase-dependent apoptosis in human lymphoblastic leukemia.吉维司他,一种II型组蛋白去乙酰化酶抑制剂,可在人淋巴细胞白血病中诱导强烈的半胱天冬酶依赖性凋亡。
Genes Cancer. 2016 Sep;7(9-10):292-300. doi: 10.18632/genesandcancer.117.